Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06937190

Pre-Sleep Creatine Enhances Anaerobic Power in Recreationally Active Females

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Ankara Yildirim Beyazıt University · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, double-blind, placebo-controlled trial designed to examine the effects of pre-sleep creatine monohydrate supplementation on anaerobic performance and muscle damage markers in recreationally active females. Participants will be randomly assigned to receive either 5 grams of creatine monohydrate or a placebo 30 minutes before sleep for seven consecutive days. Anaerobic performance will be assessed using the Wingate Anaerobic Test, evaluating peak and average power output and fatigue index. Blood samples will be collected before and after the supplementation period to analyze markers of muscle damage, including creatine kinase and lactate dehydrogenase. This study aims to provide insight into the efficacy of short-term, time-specific creatine supplementation for enhancing performance and recovery.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCreatine MonohydrateParticipants will receive 5 grams of creatine monohydrate powder dissolved in water, flavored with a sugar-free agent, 30 minutes before sleep each night for 7 days.
DIETARY_SUPPLEMENTPlacebo (Maltodextrin)Visually identical placebo (maltodextrin powder, 5 g/day), flavored with a sugar-free agent, dissolved in water and consumed 30 minutes before sleep for 7 consecutive days.

Timeline

Start date
2025-04-01
Primary completion
2025-05-10
Completion
2025-07-10
First posted
2025-04-22
Last updated
2025-04-22

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT06937190. Inclusion in this directory is not an endorsement.